Threading the biosimilar needle
Thursday, February 11, 2016 @ 7:00 PM | By Nikolas Purcell and Geoffrey Mowatt
Biosimilars, otherwise known as subsequent entry biologics or “SEBs” in Canada, are a rapidly emerging trend in health care.
Biosimilars present novel and intriguing legal issues that are quickly rising to...
Biosimilars present novel and intriguing legal issues that are quickly rising to...